Impact of mental health on disease activity in mastocytosis during COVID-19 pandemic

• Published in: Allergology International Vol. 71; no. 1; pp. 109 - 116
• Main Authors: Öztop, Nida, Demir, Semra, Beyaz, Şengül, Ünal, Derya, Çolakoğlu, Bahauddin, Büyüköztürk, Suna, Gelincik, Aslı
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01-01-2022; JAPANESE SOCIETY OF ALLERGOLOGY; Japanese Society of Allergology. Production and hosting by Elsevier B.V; Elsevier
• Subjects: Adult; Aged; COVID-19; COVID-19 - epidemiology; COVID-19 - psychology; DASS-21 scale; Fear of COVID-19; Female; Humans; Male; Mastocytosis; Mastocytosis - complications; Mental Health; Middle Aged; Original; Prospective Studies; Quarantine; SARS-CoV-2; Severity of Illness Index; Young Adult; SS; Mastocytosis; ISM; RTNP; LP; NS; Mental health; CRHR-1; tDASS-21; DASS-21 scale; CM; IQR; Fear of COVID-19; AdvSM; FCV-19S; DS; COVID-19; SCORMA; SARS-COV2; AS; CRH; MCs
• ISSN: 1323-8930; 1440-1592
• DOI: 10.1016/j.alit.2021.08.002

Mast cell-related symptoms might be influenced by mental health status in mastocytosis. In this study, we aimed to investigate the influence of mental health problems developed during the COVID-19 pandemic on the course of mastocytosis.
Mental health status in 60 adult patients with mastocytosis was prospectively evaluated with the total Depression-Anxiety-Stress Scale (tDASS-21) and Fear of COVID-19 Scale (FCV–19S) in the lockdown period (LP) and the return to normal period (RTNP) during the pandemic. The disease course was assessed from emergency and outpatient medical reports, including Scoring Mastocytosis (SCORMA) index and serum baseline tryptase levels, by telephone interviews and clinical visits.
The mean FCV-19S and median tDASS-21 scores were significantly higher in LP than RTNP (p < 0.001) and there was a positive correlation between FCV-19S and tDASS-21 in LP (r = 0.820, p < 0.001) and in RTNP (r = 0.572 p= <0.001). Disease-related symptoms including skin lesions, flushing and anaphylaxis attacks increased in 22 patients in LP, and in this group, mean FCV-19S and median tDASS-21 were higher than those without symptom exacerbation (p < 0.001). During the study period, four (6.7%) patients who experienced COVID-19 recovered without any requirement for hospitalization and had not experienced symptom exacerbation.
Fear of COVID-19 can be a reason for mental health changes, including depression, anxiety and stress which may further increase mast cell-related symptoms. Therefore, psychological support is important to control the severity of mast cell-related symptoms in mastocytosis during a pandemic.